A detailed history of Boyer & Corporon Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boyer & Corporon Wealth Management, LLC holds 113,658 shares of BMY stock, worth $6.13 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
113,658
Holding current value
$6.13 Million
% of portfolio
1.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $4.57 Million - $6.02 Million
113,658 New
113,658 $4.72 Million
Q2 2018

Aug 08, 2018

SELL
$50.53 - $62.98 $2.84 Million - $3.54 Million
-56,275 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $492,782 - $567,291
-8,224 Reduced 12.75%
56,275 $3.56 Million
Q4 2017

Feb 13, 2018

SELL
$59.94 - $65.35 $39,500 - $43,065
-659 Reduced 1.01%
64,499 $3.95 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $3.6 Million - $4.15 Million
65,158
65,158 $4.15 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boyer & Corporon Wealth Management, LLC Portfolio

Follow Boyer & Corporon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyer & Corporon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyer & Corporon Wealth Management, LLC with notifications on news.